Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.
Observe Medical is listed on Euronext Oslo under OBSRV.
Oslo, February 27, 2026 – Observe Medical ("the Company" or "Observe Medical") today releases its results for the second half and the full year of 2025. Highlights · Revenue growth: UnoMeter™ portfolio revenues of NOK 7.5 million in the second half, representing an increase of 69% from the same period in 2024. For the full year…
Oslo, 19 December 2025 – Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSRV") has received a loan commitment from Innovation Norway for a loan of NOK 15 million to support the continued commercialisation of the Company’s UnoMeter™ product portfolio, and commercial preparation for the launch of Sippi®. The availability of the loan is…
Oslo, 22 October 2025: Observe Medical ASA (the "Company") has been informed that Glimt Invest AS, a close associate to Terje Bakken, chairman of the board and primary insider of the Company, has purchased 30,000 shares in the Company as further specified in the attached notification form. This information is subject to the disclosure requirements… Observe Medical ASA: Second half and full year interim report
Observe Medical ASA – Received Innovation Norway Loan Commitment of NOK 15 million
Observe Medical ASA: Mandatory notification of trade by close associates to primary insider
Follow the development of the Observe Medical share at Oslo Stock Exchange under the OBSRV ticker. Observe Medical ASA has been listed on the Oslo Stock Exchange since November 4, 2019.
To view all stock exchange releases form the Company, please review Oslo Stock Exchange NewsWeb under the OBSRV ticker.
As at 26 February 2026
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 12 564 279 | 13.37% | 9.23% | Norway | |
| 2 | R INVESTMENT COMPANY AS | 10 703 684 | 11.39% | 7.86% | Norway | |
| 3 | SONGA CAPITAL AS | 10 000 000 | 10.64% | 7.34% | Norway | |
| 4 | JPB AS | 7 170 996 | 7.63% | 5.27% | Norway | |
| 5 | KING KONG INVEST AS | 6 333 333 | 6.74% | 4.65% | Norway | |
| 6 | JIANGSU HONGXIN MEDICAL TECHNOLO | 6 000 000 | 6.39% | 4.41% | CHINA | |
| 7 | SEED CAPITAL AS | 5 236 268 | 5.57% | 3.85% | NORWAY | |
| 8 | BJØRNTVEDT, VEGARD | 4 805 967 | 5.12% | 3.53% | Norway | |
| 9 | RO, LARS | 4 004 004 | 4.26% | 2.94% | Norway | |
| 10 | EIDCO AS | 4 000 000 | 4.26% | 2.94% | Norway | |
| 11 | LIVERMORE INVEST AS | 3 597 508 | 3.83% | 2.64% | Norway | |
| 12 | GLIMT INVEST AS | 3 005 113 | 3.20% | 2.21% | NORWAY | |
| 13 | EM KAPITAL AS | 3 000 000 | 3.19% | 2.20% | Norway | |
| 14 | SONGA X AS | 2 100 000 | 2.24% | 1.54% | Norway | |
| 15 | JJB AS | 2 100 000 | 2.24% | 1.54% | Norway | |
| 16 | AGMABLY AS | 2 100 000 | 2.24% | 1.54% | Norway | |
| 17 | AKB AS | 2 100 000 | 2.24% | 1.54% | Norway | |
| 18 | ABAGUST AS | 2 000 000 | 2.13% | 1.47% | Norway | |
| 19 | GINNY INVEST AS | 1 616 666 | 1.72% | 1.19% | Norway | |
| 20 | METAL MONKEY AS | 1 506 144 | 1.60% | 1.11% | Norway | |
| Total number owned by top 20 | 93 943 962 | 100.00% | 69.00% | |||
| Total number of shares | 136 148 412 | |||||
| Total number of shareholders | 2 313 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
Jørgen Mann, Chief Executive Officer
+45 40 86 75 58 / jørgen.mann@observemedical.com
Johan M. Fagerli, Chief Financial Officer
+47 95 81 27 65 / johan.fagerli@observemedical.com
10 October 2025:
3 July 2025:
27 June 2025:
7 January 2025:
17 July 2024: Observe Medical ASA – Minutes from Extraordinary General Meeting
26 June 2024: Observe Medical ASA – Notice of Extraordinary General Meeting
24 May 2024: Observe Medical ASA – Minutes from Annual General Meeting
3 May 2024: Notice of Annual General Meeting on 24 May 2024, including attendance, advance vote, and proxy forms
3 May 2024: Nomination Committee recommendation
3 May 2024: Observe Medical – Report of salary and other remuneration to leading personnel
22 November 2023: Observe Medical ASA – Minutes Extraordinary General Meeting
1 November 2023: Attendance and proxy form to the extraordinary general meeting
Shareholders who receive the notice electronically must log in to investor services (click on events, general meeting) for their registration
1 November 2023: Observe Medical ASA – Notice of Extraordinary General Meeting 22 November 2023
26 May 2023: Observe Medical ASA – Minutes from Annual General Meeting
26 May 2023: Represented List
5 May 2023:Notice of Annual General Meeting on 26 May 2023
5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023
5 May 2023: VPS – Investor services
5 May 2023: Nomination Committee recommendation
5 May 2023: Observe Medical – Report of salary and other remuneration to leading personnel
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee’s recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting